Welcome to our dedicated page for Aflac news (Ticker: $AFL), a resource for investors and traders seeking the latest updates and insights on Aflac stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Aflac's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Aflac's position in the market.
Aflac Incorporated reported strong first-quarter results with total revenues of $5.4 billion, net earnings of $1.9 billion, and a second-quarter cash dividend declared. Shareholders' equity increased to $23.5 billion with a return on equity of 33.0%. Aflac Japan saw net earned premiums decline in yen terms but increased profit margins. Aflac U.S. experienced growth in net earned premiums and adjusted net investment income. The board declared a dividend of $0.50 per share and $750 million was deployed to repurchase shares.
